DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

Hepatitis C Virus Interactive Patient Flow Model

Forecast the market for Hepatitis C virus across 45 countries through 2030.

The patient flow model enables you to understand:

  • How different treatment patterns will affect the size of the HCV patient population
  • How commercial objectives for your HCV brands need to change in response to reimbursement and policy shifts among payers
  • Where you should focus your commercial strategy to maximize revenue from a shrinking population
  • How restricting HCV treatment based on disease severity will affect your asset’s commercial viability

Assess the global Hepatitis C virus landscape.

Forecasts through 2030 for HCV patient population with data by country, region and treatment scenario. Contact us to learn more.

Learn more